SCHEMBL21926469

SCHEMBL21926469

c1ccc(-c2cccc(-c3nc(-c4ccc5c(c4)oc4ccccc45)nc(-c4cccc5c4oc4c5ccc5c4c4ccccc4n5-c4ccccc4)n3)c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 1/20 0.35
ALOX5 P09917 2/20 0.34
PLA2G2A P14555 3/20 0.33
PLA2G4A P47712 3/20 0.33
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
POLB P06746 1/20 0.32
TSHR P16473 1/20 0.32
BRCA1 P38398 1/20 0.32
KMT2A Q03164 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MMP12 P39900 1/20 0.32
MMP13 P45452 1/20 0.32
PLA2G10 O15496 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ATM Q13315 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
PTGER4 P35408 1/20 0.30
HCRTR1 O43613 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21926502 0.96 PRKDC (0.36) PRKDCALOX5MEN1ALDH1A1POLB
SCHEMBL21925459 0.95 PRKDC (0.34) PRKDCALOX5PLA2G2APLA2G4AMEN1
SCHEMBL21925482 0.94 PRKDC (0.35) PRKDCALOX5PLA2G2APLA2G4AALDH1A1
SCHEMBL27444664 0.94 PRKDC (0.34) PRKDCALOX5PLA2G2APLA2G4AMEN1
SCHEMBL21925512 0.94 PRKDC (0.35) PRKDCALOX5PLA2G2APLA2G4AMEN1
SCHEMBL21926466 0.94 MEN1 (0.32) PRKDCALOX5PLA2G2APLA2G4AMEN1
SCHEMBL27444670 0.93 TSHR (0.34) PRKDCALOX5PLA2G2APLA2G4AMEN1
SCHEMBL21925487 0.93 MEN1 (0.34) PRKDCMEN1ALDH1A1POLBTSHR
SCHEMBL21925488 0.93 MEN1 (0.35) PRKDCMEN1ALDH1A1POLBTSHR
SCHEMBL21192029 0.93 ALOX5 (0.39) PRKDCALOX5PLA2G2APLA2G4AMMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11690288-B2 Composition for organic optoelectronic diode, organic optoelectronic diode, and display device SAMSUNG SDI CO., LTD. (KR) 2023-06-27 US disclosed
US-11690288-B2 Composition for organic optoelectronic diode, organic optoelectronic diode, and display device SAMSUNG SDI CO., LTD. (KR) 2023-06-27 US disclosed
US-20200136057-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200136057-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE OR10J3, OCIAD2, OR51E2 PRKDC 2368/4885ALOX5 283/4885PLA2G2A 3488/4885
US-11690288-B2 Composition for organic optoelectronic diode, organic optoelectronic diode, and display device OR10J3, OCIAD2, OR51E2 PRKDC 2368/4885ALOX5 283/4885PLA2G2A 3488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.